Blood flow restriction ahead of surgery could be key.

A San Antonio researcher hopes to dispel myths about who is at risk for eating disorders while studying the interaction between binge eating disorder and food insecurity in older Hispanic women.

The Centers for Disease Control recently buried a warning about the potential for more measles outbreaks and the need for people to get vaccinated, according to a new report from ProPublica.

David Morilak, PhD, a professor of pharmacology and director of the Center for Biomedical Neuroscience at UT Health San Antonio, studies rats in an effort to understand the characteristics of stressful events that can lead to PTSD in humans.

A cutting-edge technology and an exciting recent hire hint at exciting developments in the future of precision medicine in the diagnosis and treatment of Alzheimer's disease.

Adam Salmon, PhD, studies aging in marmosets. He and his team recently concluded that an immunosuppressant called rapamycin extends the lifespan of marmosets. This has significant implications for the study of aging in humans.

A medication that appears to preserve brain function after a stroke will soon go into human trials. The San Antonio researcher who discovered the medication's potential more than two decades ago is still leading the team.

People with concussions get checked out pretty thoroughly by their doctors, but for some, there are cognitive changes and deficits that doctors don’t pick up.

Patients have been leaving the United States to try psychedelic therapies to treat their depression, PTSD, traumatic brain injuries, and substance use disorders. With so many patients finding relief, why do psychedelic therapies mostly remain illegal in the U.S., and how do psychedelics actually work?

Oral squamous cell carcinoma kills about half of the people who get it, and there have been no new treatments developed for half a century. A UT Health San Antonio dentist has developed a novel drug that may offer these patients a better chance at survival.